Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates

Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates

Introduction and Objectives: Tenofovir alafenamide (TAF) and entecavir (ETV) are both considered renal-friendly nucleoside/nucleotide analogs (NAs). However, the difference between ETV and TAF in terms of renal function remains unclear. This study aims to compare the renal safety profiles of two ant...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang Wang, Shipeng Ma, Lajpat Rai Malhi, Xiaoping Wu, Liping Liu, Xin Wan, Yuliang Zhang, Xiaopeng Li, Shanfei Ge
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Annals of Hepatology
Subjects:
Hepatitis B virus
Tenofovir alafenamide
Entecavir
Renal function
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268125001504
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items